Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Consolidated Statements of Operations

v3.24.1.1.u2
Unaudited Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended 9 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]        
Revenues, net of slotting and promotion $ 1,352 $ 10,605 $ 10,423 $ 103,944
Operating expenses        
Cost of product sold 2,034 58,474 60,610 225,591
Advertising and promotional 6,453 38,960 6,044 129,295
Selling, general and administrative expense 162,022 155,076 375,470 385,711
Professional fees 120,983 (96,850) 458,299 744,547
Total operating expenses 291,492 155,660 900,423 1,485,144
Loss from operations (290,140) (145,055) (890,000) (1,381,200)
Other income (expense)        
Interest expense - debt (86,136) (40,758) (192,872) (98,086)
Interest expense – financing cost 1,696,970 (804,160) (1,813,940)
Amortization of debt discount (165,113) (132,805) (578,853) (1,162,257)
Gain (loss) on debt extinguishment (128,330) (392,459) (128,330) (319,995)
Total other income (expense) (379,579) 1,130,948 (1,704,215) (3,394,278)
Net (Loss) (669,719) 985,893 (2,594,215) (4,775,478)
Deemed dividend on Series B Preferred Stock 48,410 (2,565,151) 69,181 1,120,514
Net income (loss) attributable to common shareholders $ (718,129) $ 3,551,044 $ (2,663,396) $ (5,895,993)
Basic net loss per common share (in Dollars per share) $ (0.006) $ 0.03 $ (0.021) $ (0.06)
Weighted average shares of capital outstanding – basic (in Shares) 127,688,758 105,672,769 126,540,836 98,556,215